Results 181 to 190 of about 19,748 (246)

Greek Consensus on Chronic Lymphocytic Leukemia (CLL) Treatment. [PDF]

Mediterr J Hematol Infect Dis
Sachanas S, Vassilakopoulos T, Angelopoulou M, Papageorgiou S, Spanoudakis E, Bouzani M, Dimou M, Panagiotidis P.   +7 more
europepmc   +1 more source

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of chronic lymphocytic leukemia [PDF]

, 2017
Greil, R., Hallek, M., Stahel, R. A.
core  

Cutaneous Epstein-Barr virus-positive polymorphous posttransplantation lymphoproliferative disorder responding to rituximab. [PDF]

JAAD Case Rep
Chen M, Hwang J, Germanas J.
europepmc   +1 more source

A Rare Case of Chronic Lymphocytic Leukemia Complicated by Myasthenia Gravis. [PDF]

J Community Hosp Intern Med Perspect
Khan E, Ilyas R, Shah S, Jiwani R, Samhouri Y, Khan C.   +5 more
europepmc   +1 more source

Chemotherapy-free treatment with acalabrutinib can benefit patients with chronic lymphocytic leukemia/small lymphocytic lymphoma who were never treated before: a plain language summary of the ELEVATE-TN study. [PDF]

Future Oncol
Sharman JP, Hakre S.
europepmc   +1 more source

Long-term outcomes of chemoimmunotherapy with obinutuzumab/chlorambucil in chronic lymphocytic leukemia. [PDF]

Blood Adv
Goede V, Fischer K, Robrecht S, Giza A, Dyer MJS, Eckart MJ, Mϋller L, Smolej L, Kutsch N, Fink AM, Stilgenbauer S, Hallek M.   +11 more
europepmc   +1 more source

Primary Diffuse Large B-Cell Lymphoma of the Urinary Bladder: A Case Report and Literature Review. [PDF]

Cureus
Salinas Mendoza S, Lora Marquez VE, Velez Roman JC.   +2 more
europepmc   +1 more source

Computational Chemistry Advances in the Development of PARP1 Inhibitors for Breast Cancer Therapy. [PDF]

Pharmaceuticals (Basel)
Twala C, Govender P, Govender K.
europepmc   +1 more source

Adjudication of Adverse Cardiovascular Events in Patients with Chronic Lymphocytic Leukaemia Treated with Ibrutinib: Deaths in GLOW or Blowing in the Wind? [PDF]

Eur Cardiol
Esposito R, Menna P, Salvatorelli E, Camilli M, Minotti G.   +4 more
europepmc   +1 more source

Disproportionality analysis of drug-associated progressive multifocal leukoencephalopathy: roles of underlying diseases and immunomodulatory therapies in FAERS. [PDF]

Front Immunol
Lin X, Qin N, He B, Chen J, Zhang Y, Wang H, Liu W.   +6 more
europepmc   +1 more source